Literature DB >> 15622480

Recent clinical features of Wilson's disease with hepatic presentation.

Teru Kumagi1, Norio Horiike, Kojiro Michitaka, Aki Hasebe, Keiko Kawai, Yoshio Tokumoto, Seiji Nakanishi, Shinya Furukawa, Yoichi Hiasa, Hidetaka Matsui, Kiyotaka Kurose, Bunzo Matsuura, Morikazu Onji.   

Abstract

BACKGROUND: We carried out this study to evaluate recent clinical features of Wilson's disease (WD) with hepatic presentation, especially in terms of age, degree of liver injury, and association with hepatocellular carcinoma (HCC).
METHODS: Sixteen patients with hepatic manifestations were diagnosed with WD in the period 1976-2003. We divided this period into two periods, "past" and "recent". The diagnosis was based on the presence of Kayser-Fleisher rings, low serum copper levels, low serum ceruloplasmin levels, increased urinary copper concentrations before or after D-penicillamine challenge, and increased hepatic copper concentrations. This retrospective study was done at Ehime University Hospital.
RESULTS: Four patients, including a pair of siblings, had a family history of WD. Four patients had parental consanguinity. There were 6 patients aged over 40 years in the recent period, whereas no patients in the past period were over 40. Four patients had neurological manifestations. Ten patients had liver cirrhosis and 5 had chronic hepatitis. Two had fatty liver without obesity. All patients in the past period had liver cirrhosis. Three patients with liver cirrhosis were found to have HCC during the follow up. All patients were treated with either D-penicillamine or trientine chloride, or both. However, four patients had to discontinue these agents due to the side effects.
CONCLUSIONS: Recently, the number of patients diagnosed with WD has been increasing, not only in terms of those with classical-type WD but also in terms of elderly patients or patients with non-cirrhotic liver injury such as fatty liver and chronic hepatitis. The various clinical features of WD should be recognized and particular attention should focus on HCC as a complication.

Entities:  

Mesh:

Year:  2004        PMID: 15622480     DOI: 10.1007/s00535-004-1466-y

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  14 in total

1.  Wilson disease: Canadian perspectives on presentation and outcomes from an adult ambulatory setting.

Authors:  A Moores; Susan Fox; Anthony Lang; Gideon M Hirschfield
Journal:  Can J Gastroenterol       Date:  2012-06       Impact factor: 3.522

2.  Wilson disease and hepatocellular carcinoma.

Authors:  Ruliang Xu; Cristina H Hajdu
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-06

3.  Liver structures of a patient with idiopathic copper toxicosis.

Authors:  Hisao Hayashi; Tsutomu Shinohara; Keisuke Goto; Yoshikazu Fujita; Yu Murakami; Ai Hattori; Yasuaki Tatsumi; Atsumi Shimizu; Takashi Ichiki
Journal:  Med Mol Morphol       Date:  2012-06-21       Impact factor: 2.309

Review 4.  Immune therapy including dendritic cell based therapy in chronic hepatitis B virus infection.

Authors:  Sk Md Fazle Akbar; Norio Horiike; Morikazu Onji
Journal:  World J Gastroenterol       Date:  2006-05-14       Impact factor: 5.742

5.  Hepatocellular carcinoma in a non-cirrhotic patient with Wilson's disease.

Authors:  Raphael Thattil; Jean-François Dufour
Journal:  World J Gastroenterol       Date:  2013-04-07       Impact factor: 5.742

Review 6.  Bilateral symmetrical basal ganglia and thalamic lesions in children: an update (2015).

Authors:  Giulio Zuccoli; Michael Paul Yannes; Raffaele Nardone; Ariel Bailey; Amy Goldstein
Journal:  Neuroradiology       Date:  2015-07-31       Impact factor: 2.804

Review 7.  Triethylene tetramine dihydrochloride (trientine) in children with Wilson disease: experience at King's College Hospital and review of the literature.

Authors:  Rachel M Taylor; Yuan Chen; Anil Dhawan
Journal:  Eur J Pediatr       Date:  2008-12-09       Impact factor: 3.183

8.  Wilson's disease in southern Brazil: a 40-year follow-up study.

Authors:  Ricardo Schmitt de Bem; Dominique Araujo Muzzillo; Marta Mitiko Deguti; Egberto Reis Barbosa; Lineu César Werneck; Hélio Afonso Ghizoni Teive
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

Review 9.  Inherited copper transport disorders: biochemical mechanisms, diagnosis, and treatment.

Authors:  Hiroko Kodama; Chie Fujisawa; Wattanaporn Bhadhprasit
Journal:  Curr Drug Metab       Date:  2012-03       Impact factor: 3.731

10.  Altered copper homeostasis underlies sensitivity of hepatocellular carcinoma to copper chelation.

Authors:  Caroline I Davis; Xingxing Gu; Ryan M Kiefer; Martina Ralle; Terence P Gade; Donita C Brady
Journal:  Metallomics       Date:  2020-12-23       Impact factor: 4.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.